There is no conclusive evidence that pregnancy adversely affects overall survival in patients with melanoma. Clinicians caring for pregnant patients should be as suspicious of changes in melanocytic nevi in these patients as they are for nonpregnant patients. Treatment of early-stage melanoma is the same irrespective of whether or not the patient is pregnant. Chemotherapeutic regimens for metastatic disease administered during pregnancy have not demonstrated significant efficacy.
|Original language||English (US)|
|Pages (from-to)||145-152, 161|
|Journal||Dermatology nursing / Dermatology Nurses' Association|
|State||Published - Apr 1 2007|
ASJC Scopus subject areas